🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaomin Zhao

Eli Lilly (United States)

ORCID: 0000-0002-1814-8586

Agricultural and Biological SciencesBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “ALS1 Deletion Increases the Proportion of Small Cells in a Candida albicans Culture Population: Hypothesizing a Novel Role for Als1”.

ALS1 Deletion Increases the Proportion of Small Cells in a Candida albicans Culture Population: Hypothesizing a Novel Role for Als1

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.895068

N/A

0DataRank · unranked

7 citations

Soon-Hwan Oh, D. A. Coleman, Lois L. Hoyer, Xiaomin Zhao

Peering Into Candida albicans Pir Protein Function and Comparative Genomics of the Pir Family

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.836632

N/A

0DataRank · unranked

7 citations

Soon-Hwan Oh, Rubi Rodriguez-Bobadilla, Vien M. Vuong, Vít Hubka, Xiaomin Zhao +2 more

Development and validation of monoclonal antibodies specific for Candida albicans Als2, Als9-1, and Als9-2

PLoS ONE(2022)10.1371/journal.pone.0269681

N/A

0DataRank · unranked

3 citations

D. A. Coleman, Xiaomin Zhao, Lois L. Hoyer, Soon-Hwan Oh